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Abstract 
 
There are relatively few studies on adolescent substance abuse treatment.  The ones that 
exist tend to be methodologically weak.  Methodologically stronger studies have usually 
found most adolescents receiving treatment to have significant reductions in substance 
use and problems in other life areas in the year following treatment.  Average rate of 
sustained abstinence after treatment is 38% (range 30-55) at 6 months and 32% at 12 
months (range 14-47).  Variables most consistently related to successful outcome are 
treatment completion, low pre-treatment substance use, and peer/parent social 
support/nonuse of substances.  There is evidence that treatment is superior to no 
treatment, but insufficient evidence to compare the effectiveness of treatment types.  The 
exception to this is that outpatient family therapy appears superior to other forms of 
outpatient treatment. 
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 There have been several reviews and commentaries on the adolescent drug 
treatment literature (e.g., Brown, 1993; Brown, Mott and Myers 1990; Bukstein, 1994; 
Davidge and Forman, 1988; Dusenbury, Khuri and Millman, 1992; Kaminer, 1994; Spicer, 
1991; U.S. Department of Health and Human Services, 1995a; Winters, Latimer and 
Stinchfield, in press).  The most thorough review has been that of Catalano, Hawkins, 
Wells, Miller and Brewer (1990/1991).  In this review Catalano and his colleagues 
identified 16 treatment outcome studies and an additional 13 studies that examined 
factors affecting treatment progress or treatment outcome.  Four of these studies were 
multi-site, multi-program evaluations (Friedman, Glickman and Morrissey, 1986; Drug 
Abuse Reporting Program (DARP) reported in Sells and Simpson, 1979; Treatment 
Outcome Prospective Study (TOPS) reported in Hubbard, Cavanaugh, Craddock and 
Rachal, 1985; and the Uniform Data Collection System (UDCS) reported in Rush, 1979).  
In their review of all of these studies, they concluded that treatment was likely better than 
no treatment, but there was no evidence that one treatment type was superior to 
another.  Pre-treatment factors associated with outcome were race, seriousness of 
substance use, criminality, and educational status.  During-treatment factors predictive of 
outcome were time in treatment for residential programs, involvement of family in 
treatment, experienced staff who used practical problem solving, and programs that 
provided comprehensive services (school, recreation, vocation, contraceptive).   Post-
treatment factors were believed to be the most important determinants of outcome.  
These included involvement in work and school, association with nonusing friends, and 
involvement in leisure activities. 
 Unfortunately, Catalano et al.’s (1990/1991) review has several limitations.  
Catalano et al. (1990/1991), as well as several other reviewers of the adolescent literature 
(e.g. Newcomb and Bentler, 1989), have pointed out that the small number of treatment 
outcome studies makes conclusions very tentative.  For comparison purposes, in the 
adult literature, there have been over 1000 studies on alcohol treatment (Miller et al., 
1995).  A second major problem concerns the poor methodological quality of the 
adolescent treatment studies that do exist.  Small sample sizes, lack of post-treatment 
follow-up, poor follow-up rates, failure to include treatment drop-outs in the results, and 
lack of control groups are characteristic of many of these studies.  Only four out the 
sixteen outcome studies cited by Catalano et al. (1990/1991) employed control groups.  
By contrast, Miller et al. (1995), in their review of alcohol treatment in adults, were able 
to draw on 219 controlled studies.  A final problem with Catalano et al.’s (1990/1991) 
review concerns their selection of studies.  In three studies the average age was 19 or 
older (DeJong and Henrich, 1980; Khuri, Millman, Hartman and Kreek, 1984; Roffman, 
Stephens, Simpson and Whitaker, 1988).  Ten studies did not report substance use either 
at discharge or post-discharge (determination of factors affecting treatment outcome 
cannot be made unless treatment outcome is known) (e.g., Barrett, Simpson and 
Lehman, 1988; DeAngelis, Koon and Goldstein, 1978; Iverson, Jurs, Johnson and Rohen, 
1978; Williams and Baron, 1982).  Finally, Catalano et al. (1990/1991) did not include 
eight studies that were available at the time and would have been appropriate to include 
(i.e., Brown, Vik and Creamer, 1989; Feigelman, Hyman and Amann, 1988; Friedman, 
1989; Harrison and Hoffman, 1987; Query, 1985; Szapocznik, Kurtines, Foote, Perez-Vidal 
and Hervis, 1983; Szapocznik, Kurtines, Foote, Perez-Vidal and Hervis, 1986; Vaglum and 
Fossheim, 1980). 
 Fortunately, there have been many additional adolescent treatment outcome 
studies published since 1991.  The purpose of the present paper is to provide a more 
comprehensive and updated review of this literature to re-examine treatment 
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effectiveness and factors related to outcome.  Only 13 out of the 53 studies in the present 
review were included in Catalano et al. (1990/1991). 
 
Inclusion Criteria 
 
 Studies were found by consulting all prior reviews and by conducting keyword 
searches of the databases ETOH, PsycINFO, and Medline using the terms adolescent, 
youth, drug, alcohol, polydrug, substance abuse, therapy and treatment.  All studies 
providing substance abuse treatment to adolescents that reported substance use results 
at discharge or post-treatment were included.  Nonpublished studies were included, 
when available, because of the possibility that published studies might be biased toward 
higher quality programs and better results.  Non-controlled studies were included 
because so few controlled studies exist.  Studies were excluded from the review only if 
the average age of the clients was <13 or >19 (i.e., Baer et al., 1992; Bensen, 1985; 
DeJong and Henrich, 1980; Gorelick, Wilkins and Wong, 1989; Holsten, 1980; Khuri et al., 
1984; Langrod, Alksne and Gomez, 1981; Nigam, Schottenfeld and Kosten, 1992; Roffman 
et al., 1988; Wilkinson and LeBreton, 1986), or if the sample size was 20 or less (i.e., Bry 
and Krinsley, 1992; Duehn, 1978; Frederiksen, Jenkins and Carr, 1976; Kaminer, 1992; 
Myers, Donahue and Goldstein, 1994; Smith, 1983; Vik, Grizzle and Brown, 1992). 
 
Organization 
 
 Study characteristics and outcome are reported in Tables 1 and 2.  Table 1 reports 
studies that combined results from different programs located in different sites (‘‘multi-
site, multi-program studies”) and Table 2 reports single program studies.  Each table 
describes, if available, the number of adolescents entering treatment, characteristics of 
the treatment population, characteristics of the treatment program(s), methodology used 
to obtain information on substance use, and results of treatment.  
 
Number of studies and publication date 
 
 The first thing apparent from Tables 1 and 2 is the small total number of studies (n 
= 53).  Although this is considerably more than identified by Catalano in 1991, it is still a 
small number compared to the number of adult studies.  It is also a very small number 
when you consider that in 1991 there were over 3000 adolescent treatment programs in 
the United States (U.S. Department of Health and Human Services, 1993).  One of the 
reasons for the small number is that research on adolescent substance abuse treatment 
is much more recent than research on adult substance abuse.  Only 3 of the studies in 
the current review were published in the 1970’s, versus 19 in the 1980’s and 32 in the 
1990’s. 
 
Client characteristics 
 
 The treatment populations appear to be homogeneous.  For studies reporting 
demographic features:  90% have an average age between 15-17 (ranging 14-19); in 96% 
of studies males comprise the majority (ranging 0-100%); and in 89% Caucasians 
comprise the majority (ranging 0-100%).  Pattern of substance abuse is also fairly similar 
between studies.  In the large majority of studies adolescents are polydrug users with 
alcohol and marijuana being the most commonly used substances.  Finally, most studies 
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identify high levels of associated family, school, legal and psychological problems.  It is 
estimated that approximately half of substance-abusing adolescents have a comorbid 
DSM mental disorder (‘‘dually-diagnosed”) (Greenbaum, Foster-Johnson and Petrila, 
1996).  The only sub-populations that have been examined to any extent in these studies 
are conduct disordered youth (6 studies) and Hispanics (3 studies).  It is important to note 
that the demographic characteristics of adolescents in these studies appear to be 
representative of the general adolescent treatment population in the United States 
(Friedman and Beschner, 1990; U.S. Department of Health and Human Services, 1995b) 
and also representative of the adolescent substance-abusing population (U.S. 
Department of Health and Human Services, 1997a).   
 
Program Characteristics 
 
 In contrast to the homogeneity of the treatment population, there is great diversity 
in the types of programs.  The main dimensions upon which they vary are their location 
(hospital or substance abuse treatment facility); their intensity (residential, day treatment, 
outpatient); their duration (few sessions to over a year); and their comprehensiveness.  
Comprehensiveness is reflected in whether the program is theoretically focused (e.g., 12 
step, outward bound) or eclectic; whether it provides a limited or broad range of services 
(i.e., just substance abuse treatment or substance abuse treatment and recreational, 
occupational, educational, psychiatric services); and the number of modalities by which 
treatment is provided (e.g., group therapy or individual, group and family therapy).   
Treatment programs can be roughly grouped into four main types, although there 
is considerable (and increasing) overlap between these programs.  The most common 
type reported in this review, is the ‘‘Minnesota model’’.  This is a short (4-6 week) 
hospital inpatient program typically offering a comprehensive range of treatment 
(individuaI counselling, group therapy, medication for comorbid conditions, family 
therapy, schooling, and recreational programming).  This type of program sometimes 
also has an AA/NA 12 step orientation and is often followed by outpatient treatment 
(Winters et al., in press).  Most of the large multi-site, multi-program treatment outcome 
studies such as the Treatment Outcome Prospective Study (TOPS) and the Chemical 
Abuse Treatment Outcome Registry (CATOR) have studied this type of program.   
 The second most common type of treatment reported in this review are outpatient 
programs (e.g., Azrin, Donohue, Besalel, Kogan and Acierno, 1994; Lewis, Piercy, 
Sprenkle and Trepper, 1990).  The focus is usually individual counselling, although 
sometimes family therapy and group treatment are also used.  Alternatively, family 
therapy is sometimes the primary treatment modality.  Outpatient treatment tends to be 
less intensive than hospital treatment (e.g. 1-2 sessions per week), but longer in duration.  
Treatment usually has no set length, varying anywhere from 1 session to 6 months, with 
a modal length of perhaps 3 months.   
 A third, less common type of treatment, is a lengthy (6 month - 2 year) 
‘‘therapeutic community’’ type program based in a specialized substance abuse 
treatment facility (Jainchill, Bhattacharya and Yagelka, 1995; Pompi, 1994).  These tend 
to be highly regimented residential settings with treatment facilitated by 
paraprofessionals, but run by the residents themselves.  Members progress through a 
hierarchy of responsibilities within this community of former substance abusers.  In the 
older, traditional therapeutic communities, adolescents comprise only a small minority of 
the treatment population (e.g., Hubbard et al., 1985; Rush, 1979; Sells and Simpson, 
1979).  However, there are newer forms of this treatment that provide services 
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exclusively to adolescents (e.g., Friedman, Schwartz and Utada, 1989; Feigelman et al., 
1988).  These programs retain the indoctrinational and highly structured nature of 
traditional therapeutic communities.  However, they are often day programs where the 
recovering adolescent lives in the home of an adolescent further progressed in 
treatment.  Because of their structured nature and length, these types of programs tend 
to have very high drop-out rates (in the present studies ranging from 34-90% with a 
median of 75%). 
 A fourth type of program is the ‘‘outward bound’’/lifeskills training type program 
(e.g., McPeake, Kennedy, Grossman and Beaulieu, 1991; Richardson, 1996).  This type of 
program is occasionally provided as the primary treatment, and sometimes as a 
supplement to other treatment types.  It is typically an intensive 3 or 4 week outing that 
exposes adolescents to a non-drug lifestyle and presents them with challenges intended 
to facilitate personal development and resistance to drugs.   
 In addition to these formal treatment programs, many high schools provide on-
site group counselling for substance use and abuse.  These programs are not included in 
the present review because they tend to target students in earlier stages of substance 
abuse and because there are virtually no published outcome studies (Wagner, Brown, 
Monti, Myers and Waldron, 1999).   
The considerable variability in the types of treatment programs in the present 
review reflects the variability in adolescent treatment programs generally (U.S. 
Department of Health and Human Services, 1995b).  However, it is important to note that 
the present studies are not proportionally representative of adolescent treatment 
programs.  The most commonly studied program in the present review is the hospital 
inpatient program, whereas the large majority of adolescents in the United States are 
treated in outpatient programs, particularly self-help groups (Friedman and Beschner, 
1990; U.S. Department of Health and Human Services, 1997a).  It is also important to 
note that because 48 of the studies presented were conducted in the United States (4 in 
Canada, 1 in Norway), the results do not necessarily reflect international adolescent 
substance abuse treatment or outcome.  
 
Methodology 
 
 The methodology used in these studies tends to be inconsistent.  There is no 
standard time period at which outcomes are typically evaluated.  Some studies have 
evaluated outcome at the end of treatment (e.g., Rush, 1979) while others have evaluated 
outcome as long at 6 years post-treatment (e.g., Feigelman et al., 1988).  The most 
common time periods in the present studies are at discharge, 6 months post-treatment 
and 12 months post-treatment.  Similarly, the window of time being assessed at outcome 
varies from ‘‘current use’’ (e.g., Grenier, 1985) to substance use in the previous 6 years 
(e.g., Feigelman et al., 1988).  The most common assessment windows are time since 
discharge or the past year.   
There are differences in how success is measured between studies.  A common 
measure in the adolescent literature is abstinence rates (reported in 31 of the present 
studies).  However, abstinence is arguably a less appropriate measure of success than 
reduction in substance use (reported in 31 of the present studies).  Focusing on the fact 
that only a minority of people are abstinent following treatment and that the proportion 
of people with sustained abstinence declines with time disguises the fact that most 
people tend to have reduced substance use as a consequence of treatment as well as 
experiencing improvements in other areas of functioning (Agosti, 1995; Valliant, 1995).  
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Secondly, while lifelong abstinence may be an appropriate long-term goal for an older 
person with many years of drug dependence, this is probably a less realistic or clinically 
essential goal for a 15 or 16 year old, at least with respect to substances such as alcohol.  
Finally, since substance abuse is typically associated with problems in various life areas 
(employment/school, social, legal, family, psychological, medical) it is reasonable to 
measure the impact of substance abuse treatment on these other areas, which was only 
done in 29 of the present studies.  The usual motivation for treatment is not the 
substance use itself, but the impact that substance abuse is having on the person’s life.  
Although there is evidence that abstinence rates are highly correlated with drug 
reduction rates and improvements in other life areas, the relationship is far from perfect 
(Brown, Myers, Mott and Vik, 1994). 
 The methodology in these studies also tends to be weak.  The current standard 
used in evaluating treatment effectiveness is to report success rates for all individuals 
that the program intended to treat.  It is useful to know the effectiveness of treatment for 
people who completed treatment versus people who dropped out prematurely.  
However, it is not appropriate to simply report success rates for people who completed 
treatment, as treatment completion is strongly associated with treatment success 
(Baekeland and Lundwall, 1975; Stark, 1992).  Also, a high success rate with treatment 
completers is not particularly useful if only a small percentage of people actually 
complete treatment.  Unfortunately, some of these studies, including the multi-program, 
multi-site CATOR study (Harrison and Hoffman, 1987; Hoffmann and Kaplan, 1991), have 
only reported results for treatment completers.  
 A poor follow-up rate is another common problem.  Adolescents who are difficult 
to contact or who refuse to participate in follow-up outcome studies are known to have 
significantly poorer outcomes than individuals who are easy to contact and cooperative 
(Stinchfield, Niforopulos and Feder, 1994).  Forty-eight percent of the studies in this 
review have follow-up rates less than 75% of those entering treatment.  Seventeen 
percent have rates below 50%. 
 Ascertainment of substance use is a problematic issue.  Many studies have relied 
exclusively on adolescent self-report for determination of substance use post-treatment.  
Adolescent self-report tends to be reasonably reliable and valid (Adair, Craddock, Miller 
and Turner, 1996; Smith, McCarthy and Goldman, 1995).  However, this is influenced by 
the demand characteristics and memory requirements of the situation.  Under reporting 
is characteristic of recent arrestees (Fendrich and Xu, 1994; Harrison, 1995; Magura and 
Kang, 1996); for less socially acceptable drugs (e.g., cocaine) (Lundy et al., 1997; Wish, 
Hoffman and Nemes, 1997); when parents are present (Aquilino, 1997); and when 
answers are given verbally (Aquilino, 1997; Turner, Lessler and Gfroerer, 1992).  
Similarly, individuals tend to be less honest about substance use after treatment than 
before treatment (Wish et al., 1997), with repeated assessments being associated with 
progressively less honest reporting (Fendrich, Mackesy-Amiti, Wislar and Goldstein, 
1997).  Retrospective reports are influenced by current substance use status, with higher 
reports of retrospective use being associated with higher current use and vice versa 
(Czarnecki, Russell, Cooper and Salter, 1990; Collins, Graham, Hansen and Johnson, 
1985).  
It is preferable to provide some corroboration of adolescent self-report.  Some 
studies have done this by means of parental report.  The problem with this is that 
parental awareness of adolescent substance use tends to be quite poor (Friedman, 
Glickman and Morrissey, 1990; Williams, McDermitt and Bertrand, submitted for 
publication).  Establishing that substance use is occurring by means of a positive report 
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by either the adolescent or parent may improve validity, but procedures that require a 
positive report by both the adolescent and parent likely decrease validity.  Studies in the 
present review that have relied exclusively on parental report (Ralph and McMenamy, 
1996; Knapp, Templar, Cannon and Dobson, 1991; Grenier, 1985) have questionable 
validity.  Other studies have corroborated adolescent self-report through urinalysis drug 
testing (Azrin et al, 1994; Feigelman et al., 1988; Jenson, Wells, Plotnick, Hawkins and 
Catalano, 1993; Joanning, Quinn, Thomas and Mullen, 1992; Lewis et al, 1990; Liddle et 
al., 1993 (as cited in Stanton and Shadish, 1997)).  Here again, although a positive drug 
testing result almost always indicates use, a negative result does not reliably indicate 
lack of use as many substances (e.g. cocaine, alcohol) are quickly metabolized and will 
not show up in urine unless testing is done within 1-2 days of use.     
 A final problem concerns how long to wait after discharge to evaluate treatment 
effectiveness.  Evaluations done at the end of treatment, or shortly thereafter, tend to 
overestimate the enduring effects of treatment (Miller and Sanchez-Craig, 1996).  
However, very long follow-up periods may also distort the effects of treatment 
depending on age of follow-up.  Longitudinal studies consistently show a steady increase 
in prevalence of drug and alcohol use peaking in the late teens to early 20’s and 
diminishing significantly thereafter (Fillmore, 1988; Kandel and Logan, 1984; Kandel and 
Raveis, 1989; Labouvie, 1996; Pape and Hammer, 1996).  Diminished use in the mid to 
late 20’s is thought to occur because adult roles (jobs, marriage, parenting) become 
incompatible with continued substance use (Kandel and Raveis, 1989; Labouvie, 1996).  
These trends are even more pronounced for heavy substance use and are consistent 
across various historical periods (Kandel and Logan, 1984; Pape and Hammer, 1996).  
Therefore, it should not be surprising that studies in the present review that have done 
follow-up in the late teens or early 20’s show very low rates of substance reduction or 
even increases (e.g., Sells and Simpson, 1979; U.S. Department of Health and Human 
Services (SROS); 1998; Marzen, 1990).  By comparison, studies providing follow-up in the 
mid 20’s tend to show fairly high rates of abstinence and substance reduction (e.g., 
Richardson, 1996; Vaglum and Fossheim, 1980). 
 This issue of natural recovery illustrates the need for control groups.  Without a 
control group it is impossible to attribute improvements to the treatment rather than 
natural recovery or a placebo effect.  Reid Hester, who, along with William Miller, have 
been pre-eminent researchers in adult alcohol abuse treatment, has commented that 
‘‘......one of the most important lessons we learned from this (treatment outcome 
research) was the value of controlled clinical trials.  Historically, a number of treatments 
have been introduced with glowing results from case studies and uncontrolled clinical 
trials only to have subsequent controlled studies find that the new treatment did not 
contribute in any significant way to outcome’’ (Hester, 1994, p.36).  Only 14 studies in the 
present review had comparison groups with either random or matched assignment to 
condition (Amini, Zilberg, Burke and Salasnek, 1982; Azrin et al., 1994; Braukmann et al., 
1985; Friedman, 1989; Grenier, 1985; Hennggeler et al., 1991; Joanning et al., 1992; 
Kaminer, Burleson, Blitz, Sussman and Rounsaville, 1998; Lewis et al., 1990; Liddle et al., 
1993 (as cited in Stanton and Shadish, 1997); Scopetta, King, Szapocznik and Tillman, 
1979 (as cited in Waldron, 1997); Szapocznik et al., 1983; Szapocznik et al., 1986; Vaglum 
and Fossheim, 1980).   
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Results 
 
Studies with serious methodological problems were excluded from the results 
section.  Specifically, studies were excluded if drop-outs were not included in the results, 
if follow-up rates were less than 75%, if only parental report was used to establish 
substance use, or if the average age of the treatment group was > 21 at time of follow-up.  
The following results are based on the 21 remaining studies (#’s 1, 3, 5, 7, 11, 12, 15, 16, 
17, 18, 19, 24, 28, 34, 36, 39, 42, 43, 47, 49, 52). 
 
Sustained Abstinence 
 
 Eight studies reported abstinence rates at discharge or post-discharge (7, 16, 17, 
18, 19, 39, 42, 47), with four of them assessing abstinence at more than one time period 
(16, 17, 42, 47).  Figure 1 is a graphic presentation of these results.  The one multi-site, 
multi-program study is identified, as are studies with repeated measures.   
 The only time periods with more than two data points are 6 months and 12 
months.  Average sustained abstinence at 6 months is 38% (range 30-55) and 32% at 12 
months (range 14-47)1.   
Although there appears to be some tendency for abstinence rates to decrease with 
time since discharge, the amount of decrease is fairly small.  Richter, Brown and Mott’s 
(1991) repeated measures study actually obtained a slight increase due to sampling 
differences between the two time periods.  The one study reporting abstinence at 
discharge (Lewis et al., 1990) found only 39-40% of adolescents receiving outpatient 
family therapy or family education were abstinent by the end of treatment.  This low rate 
of abstinence at discharge is also found in the outpatient studies not included in the 
review because of having methodological weaknesses potentially inflating success 
(studies 9, 13, 35, 48 have an average abstinence rate of 44% at discharge).  Brown et al. 
(1989) and Brown et al. (1990) have reported that 2/3rds of adolescent relapse occurs in 
the first three months post-treatment (see also Brown, 1993).  While this might be true for 
the short inpatient programs Brown and her colleagues have studied, it does not appear 
to be the case for outpatient programs, where only a minority of adolescents actually 
achieve abstinence by the end of treatment.   
 
Reduced Substance Use 
 
 Thirteen studies reported the percentage of adolescents with decreased substance 
use following treatment (3, 12, 15, 16, 18, 36, 39, 42, 47, 49, 52) or the average group 
decrease in substance use (1, 24).  In 12 out of 13 studies there was a reduction in 
substance use following treatment.  Braukmann et al. (1985) did not find group homes or 
teaching family group homes to reduce substance use in conduct disordered males.  
Most studies did not quantify the extent to which substance use had been reduced.  
Friedman, Glickman and Morrissey (1986), in their examination of 30 outpatient 
programs (sample of 5603), reported that average drug usage at discharge decreased to 
approximately 50% of pre-treatment levels.  Friedman (1989) reported a 50% reduction in 
average drug usage at 9 months post-treatment for adolescents in family therapy groups 
as well as adolescents whose parents attended parent support groups.   In Lewis et al. 
(1991), 38% of adolescents receiving outpatient family education reported reduced 
substance use at discharge and 55% receiving family therapy reported reduced 
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substance use.  At 6 months post-discharge 57% of adolescents reported reduced 
substance use in the inpatient programs studied by Brown et al. (1990) and by Richter et 
al. (1991).  At 12 months post-discharge 51-55% of adolescents reported reduced 
marijuana use in the multi-site, multi-program DATOS-A study (Hser, Grella, Hsieh and 
Anglin, 1999) and 62% reported reduced substance use in Richter et al. (1991). 
 
Functioning in Other Life Areas 
 
 Eight studies evaluated the effect of treatment on other aspects of the 
adolescent’s life (1, 3, 7, 12, 15, 24, 42, 52).  Most of these studies simply reported 
whether there were group improvements as a result of treatment and did not indicate the 
degree of improvement.  Four out of the 5 studies that examined iIlegal behaviour found 
decreases following treatment, with Braukmann et al. (1985) being the exception.  
Sixteen to 30% fewer adolescents committed an illegal act in the previous year 
compared to the year before treatment in the multi-site, multi-program DATOS-A study 
(Hser et al., 1999).  Forty-one to 48% fewer adolescents committed an illegal act in the 
previous year compared to the year before treatment in the multi-site, multi-program 
NTIES study (U.S. Department of Health and Human Services, 1997b).  The four studies 
that examined change in mental health all found improvements following treatment.  The 
three studies examining change in family problems all found improvement following 
treatment.  Two of the 3 studies examining school functioning reported improvements.  
Friedman, Glickman and Morrissey (1986) did not find improved school functioning in 
their study of 30 different outpatient programs but did find improvements in employment 
following treatment. 
 
Type of Treatment 
 
 It would be interesting to compare treatment outcome between treatment types.  
The above results are general findings across outpatient programs, outward-bound 
programs, short-term inpatient, and long-term residential programs.  Unfortunately, 
there is an insufficient number of each type of program to make comparisons.  Even if 
there were, the lack of randomized controlled studies would prevent any definitive 
conclusions.  The randomized controlled studies that have been done have focused 
primarily on types of outpatient treatment (see below).  No controlled studies have 
investigated the relative merits of the major treatment types, treatment setting, treatment 
length, or intensity.   
 
Controlled Comparisons 
 
 The evidence presented thus far indicates that the majority of adolescents who 
enter into substance abuse treatment have significantly reduced substance usage and 
significant improvements in life functioning in the year subsequent to treatment.  
However, in the absence of no-treatment control groups, the extent to which this 
improvement is due to treatment, as opposed to natural recovery, regression to the 
mean, or a placebo effect, is uncertain.  There are only two studies that provide evidence 
on this issue.  Braukmann et al. (1985) compared the effectiveness of group home 
treatment on male conduct disordered youth to a no-treatment group of matched friends.  
Although teaching-family group homes produced superior drug reductions during 
treatment, at 3 month follow-up there was no significant difference between the 
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treatment group and no-treatment group.  Grenier (1985) compared a wait control group 
to a random sample of former patients in a hospital inpatient program.  At 9 months 
post-treatment, 66% of the treatment group were not currently using drugs versus only 
20% of the control group.  Unfortunately, only parental report was used in the no-
treatment group (versus adolescent and parental report in the treatment group) and the 
follow-up rate for the no-treatment group was only 36%.  However, these methodological 
problems would normally tend to inflate improvement rates. 
 There have been 13 studies comparing the effectiveness of one treatment type 
against another.  A few of these studies employed conditions that could be construed as 
no-treatment controls.  For example, Amini et al. (1982) compared the effectiveness of 
132 day residential drug abuse treatment versus outpatient probation.  One year after 
entering treatment significant decreases in substance use and antisocial behaviour were 
found in both groups, but there was no significant difference between the groups.  
Hennggeler et al. (1991) compared four months of multisystemic family therapy to 
monthly meetings with a probation officer for conduct disordered youth in South 
Carolina.  At discharge adolescents receiving family therapy had significantly lower 
marijuana and alcohol use in the previous 3 months as compared to adolescents who 
just met with their probation officer.  Vaglum and Fossheim (1980) compared three 
different 5-6 month inpatient drug treatment programs for youths in Norway to a control 
group of individuals treated on other psychiatric wards.  At 3 years post-treatment, they 
found 24% abstinent in group 1, 56% in group 2, 45% in group 3, and 27% in the control 
group (reduced drug use in 41%, 82%, 81% and 56% respectively).  At 4.5-5.5 years post-
treatment they found 41% abstinent in group 1, 63% in group 2 and 38% in the control 
group (reduced drug use in 65%, 85%, and 61% respectively). 
 Other studies made comparisons between treatments that were both presumed to 
have beneficial effects on drug abuse.  Braukmann et al. (1985) compared teaching-
family group homes to non-teaching family group homes for male conduct disordered 
youth. Teaching-family homes specifically taught adaptive skills in the areas of 
relationship development and self-discipline.  Teaching-family group homes produced 
superior drug reductions during treatment, but there was no difference at 3 month 
follow-up.  Azrin et al. (1994) compared 15 sessions of supportive counselling to 15 
sessions of behavioural treatment (intended to restructure family and peer relations and 
improve urge control) in a small group of 26 adolescents.  At the end of treatment only 
9% of the adolescents receiving counselling were abstinent versus 73% in the 
behavioural group.  Superior improvements in school/work attendance, family relations, 
and mood were also found in the behavioural group.  Kaminer et al. (1998) compared a 
small group receiving 2-3 weeks of inpatient group therapy followed by 12 weeks of 
outpatient cognitive-behavioural group therapy to a small group receiving 2-3 weeks of 
inpatient group therapy followed by 12 weeks of outpatient interactional group therapy.  
Three months after treatment, he found significantly greater substance use reduction in 
the group receiving the cognitive-behavioural training.   
 Several studies compared family therapy to other substance abuse treatments.  
Hennggeler et al. (1991) found that at 4 years post-treatment family therapy produced 
significantly lower drug-related arrests compared to individual counselling for a group of 
conduct disordered youth in Missouri.  Friedman (1989) found no difference in substance 
use at 9 months post-treatment between a group of adolescents receiving 6 months of 
outpatient family therapy versus a group whose parents enrolled in a 6 month parent 
support group.  Joanning et al. (1992) compared 7-15 sessions of family therapy to 12 
sessions of adolescent group therapy and to 6 sessions of family drug education.  
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Substance use at discharge was found to be significantly lower in the family therapy 
condition compared to the other two conditions.  Liddle et al. (1993) (as cited in Stanton 
and Shadish, 1997) compared 16 sessions of family therapy to 16 sessions of family 
psychoeducation to 16 sessions of adolescent peer group treatment.  At 6 and 12 months 
post-treatment family therapy was more effective at reducing substance abuse and 
improving school grades than either peer group treatment or multifamily 
psychoeducation group.  Lewis et al. (1990) compared 12 session family therapy to 12 
sessions of family education.  At discharge greater substance use reduction was found in 
the family therapy group, but there were no differences in abstinence rates.  Scopetta et 
al. (1979) (as cited in Waldron, 1997) compared family therapy to family therapy plus 
systems intervention in a small sample of 33 Hispanic youths.  No difference in 
abstinence rates were observed at discharge.  Szapocznik et al. (1983) and Szapocznik et 
al. (1986) compared family therapy to ‘‘one-person family therapy” where the therapist 
attempted to change the family system through working with one family member.  Both 
techniques produced reductions in substance use at discharge and 6-12 month follow-up 
with no significant differences in effectiveness between the conditions. 
 Table 3 is a summary of all controlled comparisons and their results.  To 
summarize, there have been an insufficient number of studies comparing treatment to no 
treatment.  On the other hand, a treatment effect above and beyond natural recovery, 
placebo response, or regression to the mean is implied by the fact that 9 out of 15 
treatment comparisons found an advantage for one type of treatment over another (9 out 
of 12 if eliminating the three studies comparing variants of family therapy).  
 There are no well-designed studies providing comparisons between the main 
treatment types (outpatient, short-term inpatient, long-term residential, outward bound).  
However, there are several studies comparing variants of outpatient treatment.  There is 
preliminary evidence that behavioural or cognitive-behavioural treatment may be 
superior to supportive counselling (Azrin et al., 1994) or interactional group therapy 
(Kaminer et al., 1998).  There is good evidence that family therapy may be superior to 
other outpatient treatments.  Family therapy was more effective than other forms of non-
family outpatient treatment (individual counselling, adolescent group therapy, family 
drug education, meetings with probation officer) in five out of six studies.  The only 
comparison finding no difference was with parent support groups.  There is no evidence 
to date that one type of family therapy is superior to other types of family therapy.  The 
superiority of family therapy in substance abuse treatment has also been identified in a 
couple of recent reviews of the general family therapy literature (Stanton and Shadish, 
1997; Waldron, 1997).  
 
Variables associated with successful treatment 
 
 The variables associated with treatment success are reported in Table 4.  The 
table identifies the variable, studies finding it to be related to decreased substance use 
post-treatment, and studies finding it not to be related to decreased substance use.  
Variables are divided into pre-treatment, treatment, and post-treatment variables.  
Studies were excluded from the table if they did not use adolescent report, had follow-up 
rates <75%, or if they did not include drop-outs.   
The pre-treatment variable with the most consistent relationship to positive 
outcome is lower pre-treatment substance use, found in 6 out of 7 studies.  Peer and 
parental social support, particularly in their nonuse of substances, was related to positive 
outcome in the three studies examining this.  Better school attendance and functioning at 
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pre-treatment was related to success in 3 out of 4 studies.  Other variables with some 
evidence of a relationship to success are less conduct disorder, being employed, greater 
motivation for treatment, having fewer prior substance abuse treatments, and less 
psychopathology.  Studies examining demographic variables have not found these 
variables to be consistently related to outcome. 
 Treatment completion is the treatment variable with the most consistent 
relationship to positive outcome.   However, it is unclear whether this reflects the impact 
of treatment or is just another indicator of motivation.  Larger programs with larger 
budgets, therapist experience, and program comprehensiveness (i.e., provision of 
schooling, vocational counselling, recreational activities, birth control, etc.) were 
predictive of better outcome in a comprehensive analysis of 30 treatment programs 
(sample of 5603) by Friedman and Glickman (1986).  (Number of different services 
received has also been shown to be robustly associated with outcome for adults 
(McLellan et al., 1994)).    
Post-treatment variables related to a positive outcome are attendance in aftercare 
(motivational or treatment effect?), having nonusing parents and peers, and having 
better relapse coping skills.  Prior analyses have found post-treatment variables to be the 
most powerful predictors of post-treatment outcome in adolescents (Shoemaker and 
Sherry, 1991).  However, to some extent this is to be expected, as many post-treatment 
variables are reflections of successful treatment (e.g., better coping skills, association 
with nonusing peers, decreased interpersonal conflict, etc.). 
 
Summary 
 
 A comprehensive review of the literature on the effectiveness of adolescent 
substance abuse treatment identified 8 multi-program, multi-site studies and 45 single 
program studies.  Client characteristics have been similar between studies and 
representative of the adolescent treatment population in the United States as a whole.  
Treatment programs are diverse, however.  The three main types of treatment are 
hospital inpatient, outpatient therapy, and therapeutic community programs.  Published 
reports on hospital inpatient programs are over-represented in the literature relative to 
their actual use in treatment.  The methodology used in treatment outcome research 
studies is inconsistent with regards to the time period at which outcome is evaluated, the 
number of prior months of substance use being assessed, and how success is measured.  
Reduction in substance use is a more appropriate measure of success than abstinence, 
but is only reported in 50% of studies.  The methodology in treatment outcome studies 
also tends to be weak.  The most common problems are poor follow-up rates, lack of 
control groups, failure to include drop-outs in the results, reliance on parental rather than 
adolescent report, and follow-up periods that are either too short (at discharge) or too 
long (>3 years).  Methodologically stronger studies have usually found most adolescents 
receiving treatment to have significant reductions in substance use and problems in 
other life areas in the year following treatment.  Sustained abstinence averages 38% 
(range 30-55) at 6 months post-treatment and 32% at 12 months (range 14-47).  Pre-
treatment variables most consistently related to successful outcome are lower substance 
use, peer/parental social support, and better school functioning.  Treatment variables 
most consistently related to successful outcome are treatment completion, programs that 
provide comprehensive services, programs with experienced therapists, and larger 
programs with larger budgets.  Post-treatment variables most consistently related to 
outcome are attendance in aftercare and peer/parental social support.  There is evidence 
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that treatment is superior to no treatment, but insufficient evidence to compare the 
effectiveness of treatment types.  The exception to this is that outpatient family therapy 
appears superior to other forms of outpatient treatment.  There is no evidence 
concerning the relative merits of treatment setting, treatment length, treatment intensity, 
treating homogenous versus heterogeneous populations, or whether certain types of 
adolescents are best treated by certain types of programs. 
 
Implications and Recommendations 
 
The most obvious implication of the present review is that more and better-
designed studies need to be conducted.  There is a particular need for randomized 
controlled studies to compare treatment against no treatment and to investigate the 
advantages of treatment types, length, setting, intensity, population homogeneity, and 
patient-treatment matching.  It is recommended that these studies have the following 
methodological characteristics:  
1. The treatment population the program intended to treat should be described in terms 
of how they were selected, average age, gender, race/ethnicity, psychopathology, 
exclusionary criteria, baseline substance use, and baseline measure(s) of problems in 
other life areas.  
2. Substance use should be established by adolescent self-report along with some type 
of corroboration (i.e., biochemical analysis, third party report).  Validity will be 
enhanced if procedures are used that provide privacy, confidentiality and/or 
anonymity (e.g., self-administered questionnaires, interviews conducted by 
individuals not connected with treatment).  Validity will also be enhanced if 
procedures are used that minimize recall artifact.  An example of this is the Time-Line 
Follow-Back procedure (Sobell and Sobell, 1996) which provides the person with a 
calendar with important dates as anchors and asks him/her only to recall which 
days/weeks which substances were used, rather than to estimate overall averages or 
frequencies.  The time window being assessed should include a past month measure 
(in addition to possibly a 6 or 12 month measure), to minimize recall artifact and to 
allow for biochemical corroboration.  Baseline measure(s) of problems in other life 
areas should be obtained in a similar fashion. 
3. The nature of the treatment should be described in terms of its length, intensity, 
setting, therapist characteristics, and components (i.e., groups, individual therapy, 
schooling, recreational programming, medication, parent support, aftercare).  
4. Outcome evaluation should take place at time periods commonly used by other 
studies to allow for comparison and accumulation of data.  Evaluation at 6 and 12 
months post-treatment is currently recommended.  Documentation of the dropout 
rate, dropout characteristics, and follow-up rate is needed.  Efforts need to be made 
to ensure follow-up rates above 75%, perhaps through financial incentives (e.g., 
Richter et al., 1991; Shoemaker and Sherry, 1991; Hser et al., 1999).  When sample 
sizes are large it may be preferable to exhaustively follow a small random sample 
(e.g. 50%) than to obtain low follow-up rates for the entire sample.   
5. Post-treatment substance use and problems in life areas should be established in the 
same manner used at baseline.  Results should report reduction in substance use, 
reduction of problems in other life areas, and abstinence.  These results should be 
reported separately for the entire sample and for treatment completers.  
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It is much more difficult to make programmatic recommendations on the basis of 
the limited evidence available.  However, the evidence suggests a few things.   
1. Because treatment appears preferable to no treatment, programs should strive to be 
readily accessible and able to provide treatment for large numbers of people.   
2. Programs should develop procedures to minimize treatment dropout and to maximize 
treatment completion.   
3. Programs should attempt to provide or arrange for post-treatment aftercare.   
4. Programs should attempt to provide comprehensive services in areas other than just 
substance abuse (i.e., schooling, psychological, vocational, recreational, medical, family, 
legal).   
5. Family therapy should be a component of treatment.   
6. Programs should encourage and develop parent and peer support, especially in 
regards to nonuse of substances.   
 
There is insufficient evidence to make recommendations about other aspects of 
treatment.  However, there are two others areas of related research that may provide 
some guidance.  One is adult substance abuse treatment and the other is treatment for 
adolescent emotional/behavioural problems.  Both of these areas have clearly 
established that treatment is superior to no treatment (Agosti, 1995; Hoag and 
Burlingame, 1997; Kazdin, 1990; Mann and Borduin, 1991; Miller et al., 1995; Target and 
Fonagy, 1996; U.S. Department of Health and Human Services, 1995a; Weisz, Weiss, Han, 
Granger and Morton, 1995).   
With regards to treatment setting (outpatient, residential, inpatient), adult 
substance abuse research has found a slight advantage for inpatient over outpatient 
treatment in some circumstances (Annis, 1996; Finney, Hahn and Moos, 1996; 
Longabaugh, 1996).  The impact of treatment setting on adolescent 
emotional/behavioural problems is less well researched, but evidence to date has not 
found any differential impact on outcome (Bates, English and Kouidou-Giles, 1997; Curry, 
1991).   
Duration of treatment also has a weak effect on outcome.  A review of brief 
interventions for alcohol problems has found them often to be as effective as more 
extensive treatment (Bien, Miller and Tonigan, 1993).  It also appears that short hospital 
stays and time-limited therapy do not adversely affect mental health outcome for most 
people (Johnston and Zolese, 1999; Pfeiffer, O’Malley and Shott, 1996; Steenbarger, 
1994).  
Type of treatment is important.  When treatment advantages have been found for 
alcohol abuse they have favoured a community reinforcement approach (because of its 
comprehensiveness and behavioural orientation?), behavioural contracting, social skills 
training and motivational enhancement (Miller et al., 1995).  Behavioural treatment is 
superior to nonbehavioural treatment for adolescent emotional/behavioural problems 
(Target and Fonagy, 1996; Weisz et al., 1995).  Family therapy appears particularly 
effective for conduct disordered youth (Mann and Borduin, 1991; Target and Fonagy, 
1996).  
In general, therapist experience, training and professional discipline have a very 
weak relationship to mental health treatment outcome (Roth and Fonagy, 1996; Smith et 
al., 1980; Weiss et al., 1995), although experience may enhance client retention and 
improve outcome for more severely disturbed patients (Roth and Fonagy, 1996).  Much 
more important than training or experience is the quality of the therapeutic relationship 
between therapist and client (Horvath and Symonds, 1991; Morris and Nicholson, 1993; 
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Roth and Fonagy, 1996).  This is believed to be fostered through therapist qualities of 
flexible/intelligent thinking, good interpersonal skills, and genuine empathy (Lazarus, 
1993; Miller, 1993; Miller et al., 1995; Mohr, 1995; Najavits and Weiss, 1994). 
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Footnotes 
 
  1 Abstinence rates are similar when all 53 studies are included:  average of 39% 
abstinence at discharge, 37% at 6 months, and 35% at 12 months. 
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Table 3 
 
Controlled Comparisons of Adolescent Substance Abuse Treatment  
 
 
 
Study 
 
Atypical  
Population? 
  
 
Treatment Comparison 
 
Post-tx  
Differences 
 
 
Braukmann et al. 
(1985) 
 
conduct disordered 
males 
  
• Teaching-Family group homes 
• non-Teaching-Family group homes 
• no treatment group 
 
 
NO 
 
 
 
Grenier (1985) NO  • hospital inpatient tx 
• wait control group 
 
inpatient treatment 
superior 
Amini et al. (1982) conduct disordered  • non-hospital residential tx   
• meetings with probation officer 
NO 
 
 
Hennggeler et al. 
(1991) South Carolina 
 
conduct disordered  • multisystemic family therapy  
• meetings with probation officer 
 
family therapy superior 
Hennggeler et al. 
(1991) Missouri 
conduct disordered  • multisystemic family therapy  
• individual counselling 
 
family therapy superior 
Vaglum & Fossheim 
(1980) 
hard drug users, 
older  
 • inpatient drug tx programs 
• drug abusers treated on other wards  
2 out of 3 tx groups 
superior to control  
 
Azrin et al. (1994) NO  • behavioural tx (restructure family & 
peer relations, urge control)  
• supportive counselling  
 
behavioural treatment 
superior 
 
  
Kaminer et al. (1998) 
 
all with comorbid 
psychiatric 
problems 
 • inpatient tx followed by outpatient 
cognitive-behavioural group therapy 
• inpatient tx followed by outpatient  
interactional group therapy  
 
cognitive-behavioural 
treatment superior 
Friedman (1989) NO  • family therapy 
• parent support groups  
NO 
 
 
Joanning et al. (1992) NO  • family therapy  
• adolescent group therapy  
• family drug education  
 
family therapy superior 
 
 
Liddle et al. (1993) 
(cited in Stanton & 
Shadish, 1997) 
NO  • family therapy  
• adolescent group therapy  
• multifamily psychoeducation   
 
family therapy superior 
 
 
Lewis et al. (1990) NO  • family therapy  
• family education  
 
family therapy superior 
 
Scopetta et al. (1979) 
(cited in Waldron, 
1997) 
 
Hispanics  • family therapy  
• family therapy + systems 
intervention  
NO 
 
 
Szapocznik et al. 
(1983) 
Hispanics  • family therapy  
• one-person family therapy  
NO 
 
 
Szapocznik et al. 
(1986) 
Hispanics  • family therapy  
• one-person family  therapy  
NO 
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Table 4.  Variables Related to Reduced Substance Use Post-treatment 
 
 
 Pre-treatment Variables
  
Studies finding variable 
related to reduced substance 
use 
 
Studies finding variable not 
related to reduced substance 
use 
lower/less serious pre-tx substance use  5a, 6a, 11, 34, 43, 49 47 
peer/parent support/nonuse of substances  3, 47, 49  
school attendance & functioning  5a, 5b, 49 3 
less/no conduct disorder  3, 5a, 6a, 11, 16 5b, 16 
employed pre-tx  5a, 5b  
motivation for treatment  19, 34  
fewer prior substance abuse treatments  1  
less psychopathology  3  
  high pre-tx family functioning  28  
 higher intelligence/pre-tx skills  34  
race/ethnicity (white)  1, 5a, 6b 3, 47  
female  19, 49 32, 47 
 socioeconomic status   47 
religion   47 
family hx substance abuse   3, 47 
age   3, 47 
Treatment Variables
   
treatment completion/time in tx  1, 5a, 5b, 6a, 6b, 11, 19 32 
program comprehensiveness  1, 3  
bigger programs with larger budgets  1  
therapist experience  1  
family involvement in treatment  49  
treatment intensity   3 
Post-Treatment Variables
   
attendance in aftercare (e.g. NA/AA)  11, 43, 49  
peer/parent support/nonuse of substances  16, 47, 49 16 
better relapse coping skills  16, 34  
lower family pathology  49  
interpersonal conflict  16  
self-esteem  47  
 
Note.  Bold font represents multi-site, multi-program studies. 
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Figure 1.  Percentage of adolescents with sustained abstinence as a function of time since 
discharge.  Each data point represents a different study.  Connected data points represent 
repeated measures in the same study. 
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